These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6344327

  • 1. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C, Akai H, Umezu M, Toyota T, Goto Y.
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [Abstract] [Full Text] [Related]

  • 2. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE, Mazzaferri EL, Cataland S.
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [Abstract] [Full Text] [Related]

  • 3. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
    Ross SA, Brown JC, Dupré J.
    Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
    [Abstract] [Full Text] [Related]

  • 4. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
    Reynolds C, Tronsgard N, Gibbons E, Blix PM, Rubenstein AH.
    J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
    [Abstract] [Full Text] [Related]

  • 5. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.
    Mazzaferri EL, Starich GH, Lardinois CK, Bowen GD.
    J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608
    [Abstract] [Full Text] [Related]

  • 6. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA, Dupre J.
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [Abstract] [Full Text] [Related]

  • 7. Hypersecretion of gastric inhibitory polypeptide induced by glucose ingestion in diabetes mellitus.
    Takemura J, Seino Y, Tsuda K, Seino S, Ikeda M, Sakurai H, Imura H.
    Endocrinol Jpn; 1981 Feb; 28(1):17-21. PubMed ID: 7250066
    [Abstract] [Full Text] [Related]

  • 8. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
    Lauritsen KB, Moody AJ.
    Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
    [Abstract] [Full Text] [Related]

  • 9. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
    Coxe JS, O'Dorisio TM, Cataland S, Crockett SE.
    J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
    [Abstract] [Full Text] [Related]

  • 10. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L.
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [Abstract] [Full Text] [Related]

  • 11. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R, Frerichs H, Creutzfeldt W.
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [Abstract] [Full Text] [Related]

  • 12. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
    Kühl C, Hornnes PJ, Jensen SL, Lauritsen KB.
    Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
    [Abstract] [Full Text] [Related]

  • 13. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
    Lauritzen JB, Lauritsen KB, Olsen ME, Timmerman I.
    Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
    [Abstract] [Full Text] [Related]

  • 14. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
    Lauritsen KB, Moody AJ, Christensen KC, Lindkaer Jensen S.
    Scand J Gastroenterol; 1980 Nov; 15(7):833-40. PubMed ID: 7010526
    [Abstract] [Full Text] [Related]

  • 15. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ, Miller LJ, Service FJ, Go VL.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [Abstract] [Full Text] [Related]

  • 16. The association between plasma GIP and insulin after oral glucose.
    Lauritsen KB, Moody AJ.
    Scand J Gastroenterol; 1980 Feb; 15(8):953-7. PubMed ID: 7015475
    [Abstract] [Full Text] [Related]

  • 17. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G, Lala A, Mauceri M, Leonetti F, Andreani D.
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [Abstract] [Full Text] [Related]

  • 18. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R.
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [Abstract] [Full Text] [Related]

  • 19. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
    Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
    [Abstract] [Full Text] [Related]

  • 20. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
    Elahi D, Andersen DK, Tobin JD, Andres R.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.